Skip to the page

Data / Drug companies / Fagron Inc

Fagron Inc: 70 products in the FDA NDC directory, labeler code 51552

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Fagron Inc (labeler code 51552) lists 70 products in the FDA National Drug Code Directory. By type: 70 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on October 25, 2021.

The request: Watch Fagron Inc (FDA labeler code 51552): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
51552
Products in commercial distribution
70
Packages
169
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule II 1, Schedule III 1, Schedule IV 3
Started marketing in the last 12 months
0
Products with a marketing end date set
66
Earliest marketing start
April 1, 1998
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding6998.6%
Bulk ingredients11.4%

Products by type

TypeProductsShare
Bulk ingredients70100%

Dosage forms

Dosage formProductsShare
Powder5781.4%
Cream57.1%
Suspension34.3%
Gel11.4%
Liquid11.4%
Granule11.4%
Kit11.4%
Bead11.4%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Iron sucrose51552-1615PowderBulk ingredients for compoundingOctober 25, 2021
Chloramphenicol51552-1419PowderBulk ingredientsOctober 15, 2021
Dapsone51552-1042PowderBulk ingredients for compoundingJune 7, 2021
Clomiphene citrate51552-1580PowderBulk ingredients for compoundingOctober 22, 2020
Midazolam51552-1023PowderBulk ingredients for compoundingJuly 22, 2020
Hydroxyzine hcl51552-0485PowderBulk ingredients for compoundingJune 18, 2020
Cellulose microcrystalline51552-1528PowderBulk ingredients for compoundingDecember 11, 2018
Metoclopramide hydrochloride51552-1549PowderBulk ingredients for compoundingJanuary 12, 2018
Imiquimod51552-1538PowderBulk ingredients for compoundingJanuary 3, 2018
Lipopen absorption enhancing base51552-1504CreamBulk ingredients for compoundingOctober 15, 2016
Methocel e4m premium cr51552-1527PowderBulk ingredients for compoundingSeptember 15, 2016
Mometasone furoate51552-1510PowderBulk ingredients for compoundingSeptember 15, 2016
Metformin hcl51552-1508PowderBulk ingredients for compoundingSeptember 15, 2016
Ketoprofen ultra51552-1501PowderBulk ingredients for compoundingSeptember 15, 2016
Finasteride51552-1470PowderBulk ingredients for compoundingSeptember 15, 2016
Amlodipine besylate51552-1438PowderBulk ingredients for compoundingApril 1, 2012
Methocel k100 premium51552-1414PowderBulk ingredients for compoundingApril 1, 2012
Nourisil51552-1394GelBulk ingredients for compoundingJanuary 2, 2012
Phentermine hcl51552-1354PowderBulk ingredients for compoundingJanuary 2, 2012
Orphenadrine citrate51552-1353PowderBulk ingredients for compoundingJanuary 2, 2012
Lets kit51552-1345KitBulk ingredients for compoundingJanuary 2, 2012
Versatile cream base51552-1343CreamBulk ingredients for compoundingJanuary 2, 2012
Pentravan plus51552-1285CreamBulk ingredients for compoundingJanuary 2, 2012
Syrspend sf alka51552-1201PowderBulk ingredients for compoundingJanuary 2, 2012
Syrspend sf grape51552-1167SuspensionBulk ingredients for compoundingJanuary 2, 2012

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.